Jefferson University Hospitals

Implantable Cardioverter Defibrillator (ICD)

Cardiologists within Jefferson's Electrophysiology Laboratory are among the most experienced in the Philadelphia region in treating patients with life-threatening arrhythmias with implantable cardioverter defibrillators.

What Does Implanting an ICD Involve?

ICDs are implanted under the skin and connected to the heart via leads, which allow physicians more sophisticated remote monitoring over the Internet to detect a change in a patient's condition before the patient is even aware of it.

Lead Extraction of ICDs

The number of patients who have implantable cardioverter defibrillators is growing rapidly. There may be occasions when the device malfunctions or there are complications such as device-related blood infections. If this happens to you or someone you care for, turn to the experts at Jefferson's Electrophysiology Lab who are leading the nation in treating these conditions.

Jefferson is one of only a handful of centers in the U.S. with experience in the laser extraction procedure, which treats complications of device leads.

Transvenous lead extraction, when done by experienced physicians, can be the best way to manage device infections, veins with blockages or lead malfunctions. Jefferson not only participated in a major clinical on this lead extraction procedure, but Program Director Arnold Greenspon, MD, also published extensively on the subject, including a multicenter study, which demonstrated the high success and low complication rates of the procedure when experienced electrophysiologists are at the helm.

For more than 25 years, our arrhythmia specialists have combined outstanding patient care with groundbreaking scientific research, training and the implementation of innovative technologies and techniques.

Why Choose Jefferson for Arrhythmia Treatment in Philadelphia?

Jefferson is the first hospital in Pennsylvania and one of the first in the U.S. to offer advanced ICDs, which reduce unnecessary hospital visits and inconvenience for patients who have to travel long distances.

Jefferson cardiologists are leading researchers in heart failure, ventricular remodeling, cardiopulmonary exercise, familial genetic markers for cardiomyopathy and immunosuppression therapies. Innovative investigational approaches for detecting, understanding, treating and preventing heart failure are studied here. These trials, including drugs and monitoring devices that are not commonly available, and pharmacokinetic and genetic screening studies, offer innovative options to treat heart failure.